Product
Darbepoetin
2 clinical trials
7 indications
Indication
NeurocognitiveIndication
neuroprotectionIndication
NeonatalIndication
Neurodevelopmental ImpairmentIndication
chronic kidney diseaseIndication
HypertensionIndication
AnaemiaClinical trial
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm InfantsStatus: Active (not recruiting), Estimated PCD: 2022-12-23
Clinical trial
Mechanisms of Erythropoietin Induced HypertensionStatus: Active (not recruiting), Estimated PCD: 2024-12-31